These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6744097)

  • 1. Hypertension associated with cardiopulmonary bypass.
    Goresky GV
    Can Anaesth Soc J; 1984 Jul; 31(4):489-90. PubMed ID: 6744097
    [No Abstract]   [Full Text] [Related]  

  • 2. The current role of total intravenous anesthesia in cardiac surgery: total intravenous anesthesia and cardiopulmonary bypass.
    Schraag S
    J Cardiothorac Vasc Anesth; 2015 Jun; 29 Suppl 1():S27-30. PubMed ID: 26025043
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of preoperative renin-angiotensin system blockade on hypertension following coronary surgery.
    Colson P; Grolleau D; Chaptal PA; Ribstein J; Mimran A; Roquefeuil B
    Chest; 1988 Jun; 93(6):1156-8. PubMed ID: 3286140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of renin-angiotensin system in cardiopulmonary bypass hypertension.
    Townsend GE; Wynands JE; Whalley DG; Wong P; Bevan DR
    Can Anaesth Soc J; 1984 Mar; 31(2):160-5. PubMed ID: 6367901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collapsed anterior chamber during hypothermic cardiopulmonary bypass.
    Kubo N; Sakuragi T; Mayama T; Shinokuma T; Horie T; Dan K
    Anesth Analg; 1998 Apr; 86(4):919-20. PubMed ID: 9539635
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension and the renin-angiotensin system following open-heart surgery.
    Taylor KM; Morton IJ; Brown JJ; Bain WH; Caves PK
    J Thorac Cardiovasc Surg; 1977 Dec; 74(6):840-5. PubMed ID: 303727
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary artery bypass graft surgery without cardiopulmonary bypass: a review and nursing implications.
    Lorenz BT; Coyte KM
    Crit Care Nurse; 2002 Feb; 22(1):51-60. PubMed ID: 11852486
    [No Abstract]   [Full Text] [Related]  

  • 8. Release of vasoactive substances during cardiopulmonary bypass.
    De Souza AC; Spyt TJ
    Ann Thorac Surg; 1993 Aug; 56(2):397-8. PubMed ID: 8347041
    [No Abstract]   [Full Text] [Related]  

  • 9. Preoperative stellate-ganglion blockade to prevent hypertension following coronary-artery operations.
    Estafanous FG; Fouad FM; Tarazi RC
    Anesthesiology; 1980 May; 52(5):454. PubMed ID: 7377590
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous Levosimendan and Vasopressin in New-Onset Acute Pulmonary Hypertension After Weaning from Cardiopulmonary Bypass.
    Poidinger B; Kotzinger O; Rützler K; Kleinsasser A; Zierer A; Knotzer H
    J Cardiothorac Vasc Anesth; 2019 Feb; 33(2):328-333. PubMed ID: 30122612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration.
    De Hert SG; Van der Linden PJ; Cromheecke S; Meeus R; Nelis A; Van Reeth V; ten Broecke PW; De Blier IG; Stockman BA; Rodrigus IE
    Anesthesiology; 2004 Aug; 101(2):299-310. PubMed ID: 15277911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The renin-angiotensin system and hemodynamic changes during cardiopulmonary bypass].
    Liu GM
    Zhonghua Yi Xue Za Zhi; 1987 Nov; 67(11):600-2. PubMed ID: 3129156
    [No Abstract]   [Full Text] [Related]  

  • 13. Aortic cross-clamping phase of cardiopulmonary bypass is related to decreased microvascular reactivity after short-term ischaemia of the thenar muscle both under intravenous and volatile anaesthesia: a randomized trial.
    Biedrzycka A; Kowalik M; Pawlaczyk R; Jagielak D; Świetlik D; Szymanowicz W; Lango R
    Interact Cardiovasc Thorac Surg; 2016 Nov; 23(5):770-778. PubMed ID: 27401083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right stellate ganglion block for treatment of hypertension after cardiopulmonary bypass.
    Fee HJ; Viljoen JF; Cukingnan RA; Canas MS
    Ann Thorac Surg; 1979 Jun; 27(6):519-22. PubMed ID: 454029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine changes during anesthesia and cardiopulmonary bypass.
    El-Etr AA; Glisson SN; Balasaraswathi K
    Cleve Clin Q; 1981; 48(1):132-8. PubMed ID: 7261360
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of hypertension during cardiopulmonary bypass with cryptenamine.
    Flacke JW; Flacke WE; Williams GD; Lawson NW
    Anesth Analg; 1978; 57(1):54-62. PubMed ID: 564644
    [No Abstract]   [Full Text] [Related]  

  • 17. Volatile anesthesia during cardiopulmonary bypass.
    Alston RP
    J Cardiothorac Vasc Anesth; 2020 Nov; 34(11):3169-3170. PubMed ID: 32505606
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the cerebroprotective effect of inhalation anaesthesia and total intravenous anaesthesia in patients undergoing cardiac surgery with cardiopulmonary bypass: a systematic review and meta-analysis.
    Chen F; Duan G; Wu Z; Zuo Z; Li H
    BMJ Open; 2017 Oct; 7(10):e014629. PubMed ID: 29025825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression of pulmonary metabolic function by cardiopulmonary bypass procedures increases levels of circulating norepinephrine.
    Pitt BR; Gillis CN; Hammond GL
    Ann Thorac Surg; 1984 Nov; 38(5):508-13. PubMed ID: 6497479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe bronchospasm during cardiopulmonary bypass.
    Ecoff SA; Miyahara C; Steward DJ
    Can J Anaesth; 1996 Dec; 43(12):1244-8. PubMed ID: 8955975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.